Clinical Trial Update: Dronedarone Rhythm Intervention for Early Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for dronedarone (Multaq) in early atrial fibrillation, sponsored by Inha University Hospital, is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Multaq (dronedarone)

Snippet

Sponsor: Inha University Hospital | Conditions: Atrial Fibrillation (AF) | Phase 4 | Status: NOT_YET_RECRUITING